focus -WSS

focus

author：explore 2025-09-28 23:56:35 - browse：85

Dr. Laurie Glimcher, CEO of Dana Farber Cancer Institute, opens both arms while talking — coverage from STAT — Laurie Glimcher, CEO of Dana Farber Cancer Institute, is the architect of the biggest shakeup in Boston health care in decades. David L. Ryan/Globe Staff

Dr. Laurie Glimcher learned early on from her father, a prominent physician-researcher, that success in science was built on a basic principle: Big discoveries require big risks.

The younger Glimcher took that advice to heart. In the late 1990s at her Harvard immunology lab, Glimcher and her postdoctoral student began a series of experiments that colleagues deemed “crazy.” But after a year of trial and error, the lab had a eureka moment when it found that white blood cells could be reprogrammed, a seminal discovery that led to new ways to treat cancer.

“Most scientists do good work, but they don’t transform a scientific question,” said Glimcher. “I always felt the only way to do that is to think big and go after something that’s going to be really important.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： How Vertex's cystic fibrosis drug is changing patients' lives

WSS

What Congress can do to address the rural doctor shortage

Readout Newsletter: The latest on Moderna, Apellis, and Merck

David Ricks of Eli Lilly: best biopharma CEO of 2023

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Drug for rare kidney disease narrowly misses mark in clinical trial

Medical student insurance fails on mental health care coverage

focus

focus

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

David Ricks of Eli Lilly: best biopharma CEO of 2023

23andMe had bad news about my health. I wish a person had delivered it

Keeping primary care docs in field isn't impossible, says AAFP CEO

Novavax promises a turnaround & Lilly roils the obesity market

Medicare Advantage beneficiaries sue Humana over algorithm use

After affirmative action ruling, medical educators look to 'holistic review'

Why health records don't always know when patients are dead

How one medical school became remarkably diverse

Second xenotransplant done with gene

focus

It's been 20 years since Dolly the sheep. Where's my clone?

Senate HELP committee spars over health care workforce policies

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Virtual care provider acquires bankrupt Pear's prescription apps

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

entertainment

leisure time

Wikipedia

entertainment